Advances In Therapy SCIE

國際簡稱：ADV THER 參考譯名：治療進(jìn)展

主要研究方向：醫(yī)學(xué)-藥學(xué) 非預(yù)警期刊審稿周期：較慢,6-12周

《治療進(jìn)展》(Advances In Therapy)是一本由Springer Healthcare出版的以醫(yī)學(xué)-藥學(xué)為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
345 年發(fā)文量
3.4 IF影響因子
未開放 是否OA
53 H-index
2000 創(chuàng)刊年份
Monthly 出版周期
English 出版語言

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

[ 查看全部 ]

投稿咨詢加急咨詢

Advances In Therapy期刊信息

ISSN：0741-238X
出版語言：English
是否OA：未開放
E-ISSN：1865-8652
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Springer Healthcare
出版周期：Monthly
創(chuàng)刊時(shí)間：2000
開源占比：0.6908
Gold OA文章占比：68.88%
OA被引用占比：0.7717...
出版國人文章占比：0.07
出版撤稿占比：0
研究類文章占比：77.10%

Advances In Therapy CiteScore評價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

7.2

1.089

1.316

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Pharmacology (medical)	Q1	52 / 272	81%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Advances In Therapy中科院評價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū) 3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū) 3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 4區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū) 3區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū) 4區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū) 3區(qū)

Advances In Therapy JCR評價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	76 / 189	60.1%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	105 / 354	70.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	71 / 189	62.7%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	130 / 354	63.42%

Advances In Therapy歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Advances In Therapy中國學(xué)者發(fā)文選摘

1、The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective
Author: Zhu, Houyong; Wang, Hanxin; Zhu, Xinyu; Chen, Qilan; Fang, Xiaojiang; Xu, Xiaoqun; Ping, Yan; Gao, Beibei; Tong, Guoxin; Ding, Yu; Chen, Tielong; Huang, Jinyu

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 76-101. DOI: 10.1007/s12325-022-02343-7
2、Peripheral T-reg Levels and Transforming Growth Factor-beta (TGF beta) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis
Author: Su, Qin-Yi; Zhang, Sheng-Xiao; Yang, Liu; Luo, Jing; Li, Xiao-Feng; Zhang, Jia-Qi; Zhang, Yan; Liu, Jun-Qi; Shi, Lei

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 102-116. DOI: 10.1007/s12325-022-02337-5
3、Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer
Author: Zheng, Jian; Zhang, Yi-Fan; Han, Guo-Hui; Fan, Meng-Ying; Du, Ming-Hui; Zhang, Guo-Chen; Zhang, Bo; Qiao, Jun; Zhang, Sheng-Xiao; Cao, Ji-Min

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 310-330. DOI: 10.1007/s12325-022-02330-y
4、Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review
Author: Lohsiriwat, Varut; Sheikh, Parvez; Bandolon, Robert; Ren, Dong-Lin; Roslani, April Camilla; Schaible, Kassandra; Freitag, Andreas; Martin, Monique; Yaltirik, Pelin; Godeberge, Philippe

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 117-132. DOI: 10.1007/s12325-022-02351-7
5、Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective
Author: Xie, Wenwen; Song, Yinyin; Qin, Xiaomei; Jin, Pengfei

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 489-503. DOI: 10.1007/s12325-022-02372-2
6、Quick and Accurate Placement of Cannulated Screws to Internal Fixation of Femoral Neck Fractures Using a Novel Guide Device
Author: Ren, Bu-fang; Li, Gang; Ma, Quan-ping; Lv, Xin; Sun, Jian

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 3, pp. 844-852. DOI: 10.1007/s12325-022-02374-0
7、Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Author: Liu, Yuwei; Pan, Jiahui; Gao, Fangbo; Xu, Wentao; Li, Hongyu; Qi, Xingshun

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 521-549. DOI: 10.1007/s12325-022-02371-3
8、The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma
Author: Chen, Wenming; Liu, Aijun; Li, Lin

Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 705-717. DOI: 10.1007/s12325-022-02355-3